- Alzheimer’s cases in major markets projected to grow by 4.08% annually from 15.99 million in 2023 to 22.51 million in 2033.
- China will have the highest prevalence, with 10.4 million cases expected by 2033.
- Women make up 73% of total AD cases, with older adults (75+) comprising 79% of cases.
The global prevalence of Alzheimer’s disease (AD) is expected to surge in the coming years, with cases in eight major markets projected to rise by 4.08% annually. By 2033, the total number of AD cases will reach 22.51 million, up from 15.99 million in 2023.
The report also reveals that older adults aged 75 and above represent nearly 79% of the cases in these markets. Those aged 65-74 make up 21% of the cases, underscoring the impact of age on the disease’s prevalence.
Global Alzheimer’s Prevalence Set to Increase Dramatically in the Next Decade
Alzheimer’s disease is on the rise, with the number of prevalent cases in eight key markets projected to grow by over 4% annually over the next decade. The total number of cases is expected to reach 22.51 million by 2033, compared to 15.99 million in 2023. Among these markets, China will see the highest prevalence, with 10.4 million cases anticipated. Spain, in contrast, will have the lowest number of AD cases, with 0.62 million.
Women remain the group most affected by AD, with approximately 73% of cases in 2023 occurring among females. This gender disparity highlights the need for gender-specific research and care strategies. The report emphasizes that age is a major risk factor, with older adults aged 75 and above accounting for nearly 79% of all AD cases in 2023.
The report notes that while mild cases make up around 55% of all AD cases, severe cases—though fewer in number—continue to be a source of great concern. Effective therapies to slow disease progression are crucial for improving outcomes, as treatments that focus on reducing morbidity and extending life expectancy can significantly impact long-term care.
Given the rapid increase in AD cases, the need for comprehensive treatment strategies is more urgent than ever. These strategies should include medical interventions, lifestyle modifications, and ongoing support for patients and their families. Continued research into the relationship between Alzheimer’s and mortality is essential for improving care outcomes.
As Alzheimer’s disease cases are set to rise dramatically in the coming years, addressing the needs of affected individuals through a combination of prevention, effective treatment, and support will be critical in improving their quality of life.
“Efforts to prevent or delay the disease are expected to have a profound impact on long-term outcomes, as the value of treatment will largely depend on a therapy’s effectiveness in reducing morbidity and extending life expectancy.”
